PCS Global Cancer Conference
1st International Prostate Cancer Symposium – 2015
Theme: World Dreams of Early Diagnosis and Early Therapy of Prostate Cancer
August 8-9, 2015 Place: Beijing, China
1st International Prostate Cancer Symposium – 2015
Theme: World Dreams of Early Diagnosis and Early Therapy of Prostate Cancer
August 8-9, 2015 Place: Beijing, China
|
Registration Day Time: 8:30-22:00 (Whole day), Aug. 7, 2015 Place: Lobby of Conference Hotel |
|
Group Photo for All Delegates and Speakers Day 1: Time: 8:40-8:55 (Morning), Aug. 8, 2015 Place: TBC |
|
Session 1: Prevention and Epidemiology and Basical Research for Prostate Cancer Day 1: Time: 8:30-11:00 (Morning), Aug. 8, 2015 Conference Room: 3-1 |
|
| 9:00-9:20 |
Session Introduction Session Chair: Available (Session 1, Session 2) |
| 9:20-9:40 |
Title: Psychosocial Interventions for High Risk Prostate Patients and Survivorship Issues Dr. Suzanne M. Miller, Professor, Director, Psychosocial and Biobehavioral Medicine Program, Director, Behavioral Center of Excellence in Breast Cancer, Director, Intervention Development and Measurement Core of the Cancer Information Service Research Consortium, Fox Chase Cancer Center, USA |
| 9:40-10:00 | Speech Opportunity Available |
| 10:00-10:20 |
Title: Impact of Shared Decision Making on Adherence to Prostate Cancer Screening Dr. Zaina P Qureshi, Assistant Professor, Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia |
| 10:20-10:40 |
Title: Genetic Epidemiology of Prostate Cancer- GWAS Discoveries Dr. Ali Amin Al Olama, Centre of Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, UK |
| 10:40-11:00 |
Title: Regulation of Epithelial and Stromal AR Expression in Prostate Cancer and Therapeutic Implications Dr. Peng Lee, Professor of Pathology and Urology, New York University Langone Medical Center, School of Medicine, Staff Pathologist, New York Harbor Healthcare System, Director, Molecular Pathology, New York Harbor Healthcare System, USA |
|
Session 2: Basical Research for Prostate Cancer Day 1: Time: 11:00-17:30 (Morning), Aug. 8, 2015 Conference Room: 3-1 |
|
| 11:00-11:20 |
Title: Targeting Metabolism in Prostate Cancer: New Therapeutic Opportunities Dr. Lluis Fajas Coll, Director, the Department of Physiology, University of Lausanne, Switzerland |
| 11:20-11:40 |
Title: Unraveling the Crosstalk between Circadian Rhythm, Metabolism and Autophagy in Determinming Prostate Cancer Cell Viability Dr. Benedetto Grimaldi, Team Leader, Drug Discovery and Development, Istituto Italiano di Tecnologia (IIT), Italy |
| 11:40-12:00 |
Title: Microvesicles in Cancer Pogression and Dagnosis Dr. Khalid Al-Nedawi, Assistant Professor, Department of Medicine, McMaster University and St. Joseph's Healthcare, Canada |
| 12:00-12:20 |
Title: Integrated Genomics and Gene Expression in Prostate Cancer-A Review of the data in African Males Dr.Shingai Mutambirwa, Head of Department of Urology at Dr George Mukhari Academic hospital/Sefako Makgatho Health Science University, South Africa |
| 12:20-12:40 |
Title: An Expression Signature at Genomics of Androgen Signaling in Prostate Cancer Cells Dr. Edwin Cheung, Professor, Faculty of Health Sciences, University of Macau, Macau SAR, China |
| 12:40-13:00 |
Title: Genetic and Environmental Aspects of Prostate Cancer and the Interference of This Two in Particular of Oxidative Stress and Antioxidant Strategies Dr. Cecilia Anichini, Pediatric and Geneticist Specialist Department of Pediatry Obstetric and Reproductive Medicine, the University of Siena, Italy |
| 13:00-13:20 |
Title: A Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Interacts with Vacuolar ATPase through its Homeodomain Dr. Fei Pei, Clinical and Research Associate Professor, Department of Pathology, Health Science Center, Peking University, China |
| 13:20-13:40 |
Title: Reduction of Prostate Tumor Metastasis using a Formulation of Doxorubicin-Arg-Gly-Asp (RGD) and Modified PEGylated PLGA-encapsulated Nanocarrier in a Novel Delivery Vector. Dr. Stanley Saamoah Moffatt, Assistant Professor, NOVA Southeastern University, USA |
| 13:40-14:00 | Speech Opportunity Available |
| 14:00-17:30 |
This Session will be Separated into Two Part and the Time will be reallocated. Speech Opportunity Available in Afternoon Section |
|
Session 3: Biomarkers in Prostate Cancer Day 1: Time: 13:30-15:20 (Afternoon), Aug. 8, 2015 Conference Room: 3-1 |
|
| 13:30-13:40 |
Session Introduction Session Chair: Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark (Session 3, Session 4, Session 5) Session Co-chair: Available (Session 3, Session 4, Session 5) |
| 13:40-14:00 |
Title: Prostate Cancer Region Prediction using Hybrid Molecular and Optical Imaging for Targeted Bomarker Aalysis Dr. Frederic (Rick) D. McKenzie, Professor and Chair, Modeling, Simulation, & Visualization Engineering Dept. Joint Appointment, Electrical & Computer Engineering Dept, Old Dominion University, USA |
| 14:00-14:20 |
Title: Fatty Acd-binding Protein Fabp5 and Human Prostate Cancer ATTY Dr. Shiva Seyed Forootan, Department of Molecular and Clinical Cancer Medicine (Pathology), Faculty of Health and Life Sciences, Royal Liverpool University Hospital, UK |
| 14:20-14:40 |
Title: When Functional Magnetic Resonance Imaging met Molecular Pathology. The Crossroad of the Management of Early Prostate Cancer Dr. Olivier Cussenot, Professor, University-Paris 6, France |
| 14:40-15:00 | Speech Opportunity Available |
| 15:00-15:20 |
Title: Novel Prognostic and Predictive Biomarkers in Prostate Cancer : the AE37 Her-2/neu Vaccine Paradigm Dr. Constantin N. Baxevanis, Director, Cancer Immunology and Immunotherapy Center, Director of Cellular Immunology Dept., Cancer Immunology and Immunotherapy Dept. Greece |
|
Session 4: Diagnostics and Clinical Management in Prostate Cancer Day 1: Time: 15:20-17:20 (Afternoon), Aug. 8, 2015 Conference Room: 3-1 |
|
| 15:20-15:40 |
Title: Type-2 Diabetes & Lower Limb Amputations Identifying Predictors through Multilevel Regression Analysis Dr. Michael J.L. Smith, Director, Florida A&M University, Division of Academic Affairs, Medical Edical Scholars Program, USA |
| 15:40-16:00 |
Title: New Trends in Radiotherapy for Prostate Cancer Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark |
| 16:00-16:20 |
Title：Salvage Brachytherapy in Prostate Cancer after Failure from Radiation Treatment Dr. Ivan Henriquez, Radiation Oncology, Medical Staff, University Hospital Sant Joan, Spain |
| 16:20-16:40 | Speech Opportunity Available |
| 16:40-17:00 |
Title: Diagnostic Utility of Immunohistochemistry in Prostate Carcinoma Dr. Ankush Nayyar, Resident, Pathology, IMS and SUM Hospital, India |
| 17:00-17:20 |
Title: Artificial Neural Network for Predicting Pathological Stage of Clinically Localized Prostate Cancer in a Taiwanese Population Dr. Chih-Wei Tsao, Visiting staff, Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, China |
|
Session 5: Prostate MRI, Imaging & Biopsy Day 1: Time: 17:20-19:20 (Afternoon), Aug. 8, 2015 Conference Room: 3-1 |
|
| 17:20-17:40 |
Title: MRI-Guided Prostate Surgical Robot Dr. Andrew A. Goldenberg, Professor Emeritus, Mechanical Engineering, Consulting Engineer, Electrical and Computer Engineering, University of Toronto, Canada |
| 17:40-18:00 |
Title: MRI/US Fusion Targeted Prostate Biopsy: Technique and Contemporary Role Dr. Osamu Ukimura, Professor of Clinical Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California/Norris Cancer Center, USA |
| 18:00-18:20 |
Title: MRI of Clinically Significant Prostate Cancer: Do's and Don'ts Dr. Sergey Morozov, Head of Radiology, European Medical Center, Rector, EMC Medical School, Professor, Sechenov Moscow Medical University, Russia |
| 18:20-18:40 |
Title: Raised Serum Prostate Specific Antigen is Relatively more Common in Benign Prostatic Lesion in Transrectal Ultrasound Biopsies. A Study in Karachi Pakistan. Dr. Muhammad Abrar Barakzai, Assistant Professor, Department of Pathology, College of Medicine, Alfaisal University, USA |
| 18:40-19:00 |
Title: Comparative Effectiveness of [18 F]-fluorocholine PET-CT and Pelvic MRI with Diffusion-weighted Imaging for Staging in Patients with High-risk Prostate Cancer Dr. Jean-Baptiste Pinaquy, Department of Nuclear Medicine, France |
| 19:00-19:20 | Speech Opportunity Available |
|
Session 6: Hormone Therapy for Prostate Cancer Day 2: Time: 8:30-10:00 (Morning), Aug. 9, 2015 Conference Room: 3-1 |
|
| 8:30-8:40 |
Session Introduction Session Chair: Available (Session 6, Session 7, Session 8) Session Co-chair: Available (Session 6, Session 7, Session 8) |
| 8:40-9:00 |
Title: Rapid Development and Commercialization of a Proprietary Sustained-release Depot Formulation of Leuprolide for the Treatment of Advanced Prostate Cancer Dr. John Mao, Senior Vice President and Head of Development, Foresee Pharmaceuticals, USA |
| 9:00-9:20 |
Title: Use of Androgen Deprivation Therapy for Prostate Cancer or for Patients with Prostate Cancer: When and How? Dr. Max Ning, Senior Clinical Reviewer, OHOP/OND/FDA, USA |
| 9:20-9:40 |
Title: Integrative Genetic and Epigenetic Analyses Identify Driver Long Noncoding RNAs in Prostate Cancer Dr. Housheng Hansen He, Assistant Professor, Department of Medical Biophysics, University of Toronto; Scientist, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada |
| 9:40-10:00 | Speech Opportunity Available |
|
Session 7: New Radiation Therapy of Prostate Cancer Day 2: Time: 10:20-11:00 (Morning), Aug. 9, 2015 Conference Room: 3-1 |
|
| 10:00-10:20 | Speech Opportunity Available |
| 10:20-10:40 |
Title: 20 Years Brachytherapy at the Hotel Dieu de Quebec; Evolution and Shift of Paradigm Dr. Andre-Guy Martin, Radio-oncologue, Curiethérapeute, Professeur Associé, University Laval, Canada |
| 10:40-11:00 |
Title: Proton Therapy Quality Assurance of Prostate Cancer Dr Khalid Iqbal, Medical Physicist, Cancer Hospital&Research Centre, Pakistan |
|
Session 8: Surgical Treatment of Prostate Cancer Day 2: Time: 10:50-12:40 (Morning), Aug. 9, 2015 Conference Room: 3-1 |
|
| 11:00-11:20 |
Title: Functional Recovery after Radical Prostatectomy Dr. Charles Mooney, Medical Director, Occupational Medicine Dept. McFarland Clinic, USA |
| 11:20-11:40 |
Title: The Role of Radical Prostatectomy in the Treatment of Advanced Prostate Cancer Dr. Gang Zhu, Professor of Urology, Consultant Urological and Laparoscopic Surgeon, Department of Urology, Beijing Hospital, China |
| 11:40-12:00 |
Title: Laparoscopic Radical Prostatectomy Step by Step: Functional ad Oncological Results after 1000 Cases Dr. Mario Falsaperla, University of Catania, Italy |
| 12:00-12:20 |
Title: The Cost-effectiveness of Radical Prostatectomy Compared with Active Surveillance for Localised Prostate Cancer Dr. Chunhuan Lao, Waikato Clinical School, University of Auckland, Peter Pothwell Academic Centre, New Zealand |
| 12:20-12:40 | Speech Opportunity Available |
|
Session 9: Metastasis and Progression of Prostate Cancer Day 2: Time: 13:30-15:40 (Afternoon), Aug. 9, 2015 Conference Room: 3-1 |
|
| 13:30-13:40 |
Session Introduction Session Chair: Available (Session 9, Session 10, Session 11, Session 12) Session Co-chair: Available (Session 9, Session 10, Session 11, Session 12) |
| 13:40-14:00 |
Title: TBD Dr. Denong Wang (TBC), Distinguished Scientist and Senior Program Director, Tumor Glycomics Laboratory, SRI International Biosciences Division, USA |
| 14:00-14:20 |
Title: MicroRNAs and Reactive Oxygen Species in Prostate Cancer Development and Angiogenesis Dr. Bing-Hua Jiang, Professor, Department of Pathology, Anatomy and Cell Biology; and Kimmel Cancer Center, Thomas Jefferson University, USA |
| 14:20-14:40 |
Title: Novel Prostate Cancer Bone Metastasis Models for Studies of Metastasis Mechanism and Drug Resistance Dr Bin-Zhi Qian, Principle Investigator, Academic Research Fellow, Edinburgh Cancer Research UK Centre & MRC University of Edinburgh Centre for Reproductive Health College of Medicine Research Institute University of Edinburgh, UK |
| 14:40-15:00 |
Title: Investigation of Lymph Nodes in Experimental Prostate Cancer Dr. Astashov Vadim, Professor, Head of the Laboratory of Experimental Pharmacology Research Institute of Chemical Diversity, Moscow, Russia |
| 15:00-15:20 |
Title: Identification of a luminal Prostate Stem Cell in Animal Models and Recurrent Castration Resistant Prostate Cancer Dr. Jens Adam Ceder, Research Fellow, Lund University, Department of Translational Medicine, Division of Urological Research, Sweden |
| 15:20-15:40 | Speech Opportunity Available |
|
Session 10: Emerging Therapies and Treatment Options in Prostate Cancer (I) Day 2: Time: 15:40-17:20 (Afternoon), Aug. 9, 2015 Conference Room: 3-1 |
|
| 15:40-16:00 |
Title: Prostate Cancer Stem Cells: Molecular Regulation and Therapeutic Targeting Dr. Dean G. Tang, Professor, Department of Molecular Carcinogenesis, University of Texas, USA |
| 16:00-16:20 |
Title: TRPM8 Channel as a Novel Molecular Target in Androgen-regulated Prostate Cancer Cells Dr. Eleonora Zakharian, Assistant Professor, Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine at Peoria, USA |
| 16:20-16:40 |
Title: Anesthesia for Robotic Prostatectomy: Challenges, Management, and Safe Clinical Discharge Criteria from the Operating Room Dr. Menekse Oksar, Assistant professor of Anesthesiology and Reanimation, Mustafa Kemal University Medical Faculty, Anestehsiology and Reanimation Department, Turkey |
| 16:40-17:00 |
Title: Bioengineered Viral Vectors for Targeting and Killing Prostate Cancers. Dr. Kevin (KAI-XIN) ZHANG, The Vancouver Prostate Centre, University of British Columbia, Canada |
| 17:00-17:20 | Speech Opportunity Available |
|
Session 11: Emerging Therapies and Treatment Options in Prostate Cancer (II) Day 2: Time: 17:20-18:40 (Afternoon), Aug. 9, 2015 (Session time will be re-arranged) Conference Room: 3-1 |
|
| 17:20-17:40 |
Title: Targeting Amino Acid Transporters as a Novel Therapy for Prostate Cancer Dr. Qian (Kevin) Wang, Senior Research Fellow, Central Clinical School, University of Sydney, Australia |
| 17:40-18:00 |
Title: High Intensity Focused Ultrasound for Prostate Cancer Treatment - status Quo 2015 Dr. Vyacheslav Solovov, Professor, Head of the Interventional Oncology Department, Samara Oncology Center, Russia |
| 18:00-18:20 |
Title: Latest Trends in Prostate Cancer Biosensors- An Early Detection Tool Dr. Mansoor Aninajeeb N., University of Malaya, Malaysia |
| 18:20-18:40 |
Title: Newer CYP 26 Enzyme Inhibitors as a more Selective and Effective Therapy in the Battle of Cancer; Design Synthesis and Optimization Dr. Mohamed Gomaa, Faculty of Pharmacy, Suez Canal University, Egypt |
| 18:40-19:00 | Speech Opportunity Available |
|
Session 12: The Challenges of Managing and Supporting the Complex Advanced Prostate Cancer Day 2: Time: 18:40-20:00 (Afternoon), Aug. 9, 2015 (Session time will be re-arranged) Conference Room: 3-1 |
|
| 19:00-19:20 | Speech Opportunity Available |
| 19:20-19:40 |
Title: Emerging Therapies for MCRPC Dr. Joseph W. Kim, Assistant Professor, Yale University School of Medicine, USA |
| 19:40-20:00 |
Title: TBD Dr. Simona Di Francesco, Department of Medicine and Aging, University G. D’Annunzio Chieti-Pescara, Chieti, Italy |
